Logo image
Respiratory function and evaluation in individuals with facioscapulohumeral muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network
Journal article   Open access   Peer reviewed

Respiratory function and evaluation in individuals with facioscapulohumeral muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network

Katherine D Mathews, Jonathan Suhl, Kristin M Conway, Amy Moore, Joyce T. Alese, Russell J Butterfield, Paul A Romitti and Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet)
Neuromuscular disorders : NMD, Vol.46, 105240
01/2025
DOI: 10.1016/j.nmd.2024.105240
PMCID: PMC11911087
PMID: 39579597
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11911087/pdf/nihms-2041965.pdfView
Open Access

Abstract

•Respiratory testing is uncommon in the clinical management of people with FSHD.•Impaired respiratory function was observed among people without known risk factors.•Respiratory insufficiency may be a common complication among people with FSHD.•Regular monitoring of respiratory function for people with FSHD is supported. Using data from the US population-based, multisite Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), we describe respiratory testing and insufficiency among people with facioscapulohumeral muscular dystrophy (FSHD) diagnosed during 2008-2016. We calculated frequencies and proportions for selected outpatient respiratory assessments (pulmonary function tests [PFTs], forced vital capacity (FVC), inspiratory/expiratory pressure, and polysomnograms) and abnormal test results. We examined frequencies by disease characteristics (FSHD type, ages of onset, non-ambulatory status, scoliosis, lordosis), obesity, and number of health encounters. Of 170 people with FSHD, 20.0% underwent PFTs during 2008-2016. Polysomnograms were infrequent (14.1%). FVC <80% predicted was recorded for 64.7% of people tested; additional respiratory outcomes were rare (<5%). Frequency of evaluations and respiratory insufficiency were higher among those with known risk factors and longer follow-up. We observed low proportions of respiratory testing among all confirmed cases of FSHD, but relatively high proportions of mild respiratory insufficiency among those tested. The higher proportions of testing among people with conditions that increase risk of respiratory complications suggest targeted monitoring. Broad implementation of the FSHD guidelines recommending all individuals receive baseline respiratory evaluation at diagnosis could identify respiratory insufficiency as a complication of FSHD.
Muscular Dystrophy facioscapulohumeralrespiratory insufficiency guidelines surveillance

Details

Metrics

Logo image